US Stock MarketDetailed Quotes

PLSE Pulse Biosciences

Watchlist
  • 16.600
  • +0.940+6.00%
Close Mar 28 16:00 ET
  • 16.600
  • 0.0000.00%
Post 20:01 ET
1.09BMarket Cap-18.04P/E (TTM)

Pulse Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
0
Gross profit
0
Operating expense
29.11%56.26M
61.66%20.26M
21.36%13.66M
14.66%11.73M
11.01%10.62M
-6.92%43.57M
68.34%12.53M
16.90%11.25M
-20.94%10.23M
-43.11%9.56M
Selling and administrative expenses
51.62%23.92M
102.77%9.6M
57.46%5.95M
27.37%4.5M
3.78%3.87M
-39.26%15.78M
41.31%4.73M
-26.00%3.78M
-52.79%3.53M
-62.82%3.73M
-Selling and marketing expense
----
----
----
----
----
--0
----
----
----
----
-General and administrative expense
51.62%23.92M
102.77%9.6M
57.46%5.95M
27.37%4.5M
3.78%3.87M
13.06%15.78M
83.35%4.73M
22.41%3.78M
-6.79%3.53M
-17.01%3.73M
Research and development costs
16.33%32.34M
36.71%10.66M
3.09%7.7M
7.96%7.23M
15.65%6.74M
33.39%27.8M
90.45%7.8M
65.42%7.47M
22.70%6.7M
-13.89%5.83M
Operating profit
-29.11%-56.26M
-61.66%-20.26M
-21.36%-13.66M
-14.66%-11.73M
-11.01%-10.62M
24.95%-43.57M
-43.32%-12.53M
37.58%-11.25M
27.02%-10.23M
44.64%-9.56M
Net non-operating interest income expense
95.89%2.67M
46.00%876K
42.13%975K
8.20%343K
300.00%478K
404.46%1.36M
232.74%600K
5,000.00%686K
1,661.11%317K
-239K
Non-operating interest income
--2.67M
--876K
42.13%975K
8.20%343K
----
----
----
--686K
1,661.11%317K
----
Total other finance cost
----
----
----
----
-300.00%-478K
-404.46%-1.36M
----
----
----
--239K
Other net income (expense)
Income before tax
-26.95%-53.59M
-62.45%-19.39M
-20.01%-12.68M
-14.86%-11.38M
-3.43%-10.14M
27.85%-42.21M
-29.75%-11.93M
41.43%-10.57M
29.19%-9.91M
43.26%-9.8M
Income tax
0
0
0
0
0
0
0
0
Net income
-26.95%-53.59M
-62.45%-19.39M
-20.01%-12.68M
-14.86%-11.38M
-3.43%-10.14M
27.85%-42.21M
-29.75%-11.93M
41.43%-10.57M
29.19%-9.91M
43.26%-9.8M
Net income continuous Operations
-26.95%-53.59M
-62.45%-19.39M
-20.01%-12.68M
-14.86%-11.38M
-3.43%-10.14M
27.85%-42.21M
-29.75%-11.93M
41.43%-10.57M
29.19%-9.91M
43.26%-9.8M
Minority interest income
Net income attributable to the parent company
-26.95%-53.59M
-62.45%-19.39M
-20.01%-12.68M
-14.86%-11.38M
-3.43%-10.14M
27.85%-42.21M
-29.75%-11.93M
41.43%-10.57M
29.19%-9.91M
43.26%-9.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-26.95%-53.59M
-62.45%-19.39M
-20.01%-12.68M
-14.86%-11.38M
-3.43%-10.14M
27.85%-42.21M
-29.75%-11.93M
41.43%-10.57M
29.19%-9.91M
43.26%-9.8M
Basic earnings per share
-6.32%-0.92
-37.58%-0.31
-10.53%-0.21
9.09%-0.2
30.77%-0.177
48.84%-0.8653
8.34%-0.2253
60.57%-0.19
49.15%-0.22
55.17%-0.2557
Diluted earnings per share
-6.32%-0.92
-37.58%-0.31
-10.53%-0.21
9.09%-0.2
30.77%-0.177
48.84%-0.8653
8.34%-0.2253
60.57%-0.19
49.15%-0.22
55.17%-0.2557
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue 0
Gross profit 0
Operating expense 29.11%56.26M61.66%20.26M21.36%13.66M14.66%11.73M11.01%10.62M-6.92%43.57M68.34%12.53M16.90%11.25M-20.94%10.23M-43.11%9.56M
Selling and administrative expenses 51.62%23.92M102.77%9.6M57.46%5.95M27.37%4.5M3.78%3.87M-39.26%15.78M41.31%4.73M-26.00%3.78M-52.79%3.53M-62.82%3.73M
-Selling and marketing expense ----------------------0----------------
-General and administrative expense 51.62%23.92M102.77%9.6M57.46%5.95M27.37%4.5M3.78%3.87M13.06%15.78M83.35%4.73M22.41%3.78M-6.79%3.53M-17.01%3.73M
Research and development costs 16.33%32.34M36.71%10.66M3.09%7.7M7.96%7.23M15.65%6.74M33.39%27.8M90.45%7.8M65.42%7.47M22.70%6.7M-13.89%5.83M
Operating profit -29.11%-56.26M-61.66%-20.26M-21.36%-13.66M-14.66%-11.73M-11.01%-10.62M24.95%-43.57M-43.32%-12.53M37.58%-11.25M27.02%-10.23M44.64%-9.56M
Net non-operating interest income expense 95.89%2.67M46.00%876K42.13%975K8.20%343K300.00%478K404.46%1.36M232.74%600K5,000.00%686K1,661.11%317K-239K
Non-operating interest income --2.67M--876K42.13%975K8.20%343K--------------686K1,661.11%317K----
Total other finance cost -----------------300.00%-478K-404.46%-1.36M--------------239K
Other net income (expense)
Income before tax -26.95%-53.59M-62.45%-19.39M-20.01%-12.68M-14.86%-11.38M-3.43%-10.14M27.85%-42.21M-29.75%-11.93M41.43%-10.57M29.19%-9.91M43.26%-9.8M
Income tax 00000000
Net income -26.95%-53.59M-62.45%-19.39M-20.01%-12.68M-14.86%-11.38M-3.43%-10.14M27.85%-42.21M-29.75%-11.93M41.43%-10.57M29.19%-9.91M43.26%-9.8M
Net income continuous Operations -26.95%-53.59M-62.45%-19.39M-20.01%-12.68M-14.86%-11.38M-3.43%-10.14M27.85%-42.21M-29.75%-11.93M41.43%-10.57M29.19%-9.91M43.26%-9.8M
Minority interest income
Net income attributable to the parent company -26.95%-53.59M-62.45%-19.39M-20.01%-12.68M-14.86%-11.38M-3.43%-10.14M27.85%-42.21M-29.75%-11.93M41.43%-10.57M29.19%-9.91M43.26%-9.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -26.95%-53.59M-62.45%-19.39M-20.01%-12.68M-14.86%-11.38M-3.43%-10.14M27.85%-42.21M-29.75%-11.93M41.43%-10.57M29.19%-9.91M43.26%-9.8M
Basic earnings per share -6.32%-0.92-37.58%-0.31-10.53%-0.219.09%-0.230.77%-0.17748.84%-0.86538.34%-0.225360.57%-0.1949.15%-0.2255.17%-0.2557
Diluted earnings per share -6.32%-0.92-37.58%-0.31-10.53%-0.219.09%-0.230.77%-0.17748.84%-0.86538.34%-0.225360.57%-0.1949.15%-0.2255.17%-0.2557
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------
Market Insights
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Cisco
CSCO
-0.88%
NVIDIA
NVDA
-1.58%
Broadcom
AVGO
-1.67%
Taiwan Semiconductor
TSM
-1.78%
ASML Holding
ASML
-2.32%

Unlock the Full List